Elevated Plasma Midkine and Pleiotrophin Levels in Patients with Systemic Lupus Erythematosus

Overview

Journal Oncotarget

Specialty Oncology

Date 2016 Dec 2

PMID 27903979

Citations 7

Authors

Guo-Cui Wu

Hui Yuan

Hai-Feng Pan

Dong-Qing Ye

Affiliations

Soon will be listed here.

Abstract

Emerging evidence suggests that two heparin-binding growth factor, midkine and pleiotrophin are implicated in the pathogenesis of autoimmune diseases including SLE. To investigate the plasma midkine and pleiotrophin levels in SLE patients, as well as their correlation with major clinical parameters and interleukin-17 (IL-17) level in SLE, 83 SLE patients and 123 controls including 20 rheumatoid arthritis (RA) patients, 21 Sjögren's syndrome (SS) patients and 82 healthy controls (HCs) were recruited. Plasma midkine, pleiotrophin and IL-17 levels were detected by ELISA. Midkine and pleiotrophin levels were significantly higher in SLE, RA and SS patients compared with HCs (all P < 0.05). There were significantly lower midkine and pleiotrophin levels in SLE compared to SS (P < 0.05 and P < 0.01, respectively). No significant differences in midkine and pleiotrophin levels were found between SLE and RA (P = 0.240 and P = 0.074, respectively). Both plasma midkine and pleiotrophin levels were associated with rash and anti-SSA in SLE. In addition, both midkine and pleiotrophin levels were positively associated with IL-17 level in SLE (both P < 0.001). Area under curve (AUC) of the receiver operating characteristic (ROC) curve for midkine and pleiotrophin were 0.606 (0.527-0.681) and 0.605 (0.526-0.680) respectively. In conclusion, elevated plasma midkine and pleiotrophin levels and their associations with rash, anti-SSA and IL-17 in SLE patients suggest their involvement in this disease.

Citing Articles

Single-Cell Transcriptome Reveals the Heterogeneity of T Cells in Mice with Systemic Lupus Erythematosus and Neuronal Inflammation.

Shi Z, Qin H, Wu H J Inflamm Res. 2024; 17:11375-11402.

PMID: 39735894 PMC: 11675326. DOI: 10.2147/JIR.S474211.

The role of midkine in health and disease.

Neumaier E, Rothhammer V, Linnerbauer M Front Immunol. 2023; 14:1310094.

PMID: 38098484 PMC: 10720637. DOI: 10.3389/fimmu.2023.1310094.

Evaluation of serum midkine levels and metabolic parameters in patients with hidradenitis suppurativa.

Ayvaz Celik H, Korkmaz S Arch Dermatol Res. 2023; 315(7):1909-1914.

PMID: 36843094 DOI: 10.1007/s00403-023-02578-6.

Human macrophages and monocyte-derived dendritic cells stimulate the proliferation of endothelial cells through midkine production.

Said E, Al-Dughaishi S, Al-Hatmi W, Al-Reesi I, Al-Riyami M, Al-Balushi M PLoS One. 2022; 17(4):e0267662.

PMID: 35476724 PMC: 9045650. DOI: 10.1371/journal.pone.0267662.

The Serum Level of Midkine in Patients With Multiple Sclerosis and Neuromyelitis Optica.

Moayednia M, Dehghani L, Safi A, Shaygannejad V, Sohrabi K, Rezvani M Basic Clin Neurosci. 2021; 12(2):199-204.

PMID: 34925716 PMC: 8672672. DOI: 10.32598/bcn.12.2.1009.2.

References

Horiba M, Kadomatsu K, Nakamura E, Muramatsu H, Ikematsu S, Sakuma S . Neointima formation in a restenosis model is suppressed in midkine-deficient mice. J Clin Invest. 2000; 105(4):489-95. PMC: 289157. DOI: 10.1172/JCI7208. View

Sato W, Kadomatsu K, Yuzawa Y, Muramatsu H, Hotta N, Matsuo S . Midkine is involved in neutrophil infiltration into the tubulointerstitium in ischemic renal injury. J Immunol. 2001; 167(6):3463-9. DOI: 10.4049/jimmunol.167.6.3463. View

Gladman D, Ibanez D, Urowitz M . Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002; 29(2):288-91. View

Vitali C, Bombardieri S, Jonsson R, Moutsopoulos H, Alexander E, Carsons S . Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002; 61(6):554-8. PMC: 1754137. DOI: 10.1136/ard.61.6.554. View

Stoica G, Kuo A, Powers C, Bowden E, Sale E, Riegel A . Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types. J Biol Chem. 2002; 277(39):35990-8. DOI: 10.1074/jbc.M205749200. View

Muramaki M, Miyake H, Hara I, Kamidono S . Introduction of midkine gene into human bladder cancer cells enhances their malignant phenotype but increases their sensitivity to antiangiogenic therapy. Clin Cancer Res. 2003; 9(14):5152-60. View

Maruyama K, Muramatsu H, Ishiguro N, Muramatsu T . Midkine, a heparin-binding growth factor, is fundamentally involved in the pathogenesis of rheumatoid arthritis. Arthritis Rheum. 2004; 50(5):1420-9. DOI: 10.1002/art.20175. View

Hayakawa I, Hasegawa M, Matsushita T, Yanaba K, Kodera M, Komura K . Increased cutaneous T-cell-attracting chemokine levels in sera from patients with systemic sclerosis. Rheumatology (Oxford). 2005; 44(7):873-8. DOI: 10.1093/rheumatology/keh625. View

Yuki T, Ishihara S, Rumi M, Ortega-Cava C, Kadowaki Y, Kazumori H . Increased expression of midkine in the rat colon during healing of experimental colitis. Am J Physiol Gastrointest Liver Physiol. 2006; 291(4):G735-43. DOI: 10.1152/ajpgi.00388.2005. View

10.

Yamamoto H, Muramatsu H, Nakanishi T, Natori Y, Sakuma S, Ishiguro N . Midkine as a molecular target: comparison of effects of chondroitin sulfate E and siRNA. Biochem Biophys Res Commun. 2006; 351(4):915-9. DOI: 10.1016/j.bbrc.2006.10.123. View

11.

Wang J, Takeuchi H, Sonobe Y, Jin S, Mizuno T, Miyakawa S . Inhibition of midkine alleviates experimental autoimmune encephalomyelitis through the expansion of regulatory T cell population. Proc Natl Acad Sci U S A. 2008; 105(10):3915-20. PMC: 2268842. DOI: 10.1073/pnas.0709592105. View

12.

Krzystek-Korpacka M, Neubauer K, Matusiewicz M . Circulating midkine in Crohn's disease: clinical implications. Inflamm Bowel Dis. 2009; 16(2):208-15. DOI: 10.1002/ibd.21011. View

13.

Krzystek-Korpacka M, Neubauer K, Matusiewicz M . Clinical relevance of circulating midkine in ulcerative colitis. Clin Chem Lab Med. 2009; 47(9):1085-90. DOI: 10.1515/CCLM.2009.248. View

14.

Asari A, Kanemitsu T, Kurihara H . Oral administration of high molecular weight hyaluronan (900 kDa) controls immune system via Toll-like receptor 4 in the intestinal epithelium. J Biol Chem. 2010; 285(32):24751-8. PMC: 2915711. DOI: 10.1074/jbc.M110.104950. View

15.

Aletaha D, Neogi T, Silman A, Funovits J, Felson D, Bingham 3rd C . 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010; 62(9):2569-81. DOI: 10.1002/art.27584. View

16.

Ramos P, Williams A, Ziegler J, Comeau M, Guy R, Lessard C . Genetic analyses of interferon pathway-related genes reveal multiple new loci associated with systemic lupus erythematosus. Arthritis Rheum. 2011; 63(7):2049-57. PMC: 3128183. DOI: 10.1002/art.30356. View

17.

Jacob N, Stohl W . Cytokine disturbances in systemic lupus erythematosus. Arthritis Res Ther. 2011; 13(4):228. PMC: 3239336. DOI: 10.1186/ar3349. View

18.

Apostolidis S, Lieberman L, Kis-Toth K, Crispin J, Tsokos G . The dysregulation of cytokine networks in systemic lupus erythematosus. J Interferon Cytokine Res. 2011; 31(10):769-79. PMC: 3189553. DOI: 10.1089/jir.2011.0029. View

19.

Weckbach L, Muramatsu T, Walzog B . Midkine in inflammation. ScientificWorldJournal. 2012; 11:2491-505. PMC: 3253530. DOI: 10.1100/2011/517152. View

20.

Sonobe Y, Li H, Jin S, Kishida S, Kadomatsu K, Takeuchi H . Midkine inhibits inducible regulatory T cell differentiation by suppressing the development of tolerogenic dendritic cells. J Immunol. 2012; 188(6):2602-11. DOI: 10.4049/jimmunol.1102346. View